FDA, GLP-1 and suicidal
Digest more
The FDA is weighing a change that could make warning labels on dietary supplements appear less often on packaging.
Miach Orthopaedics' BEAR Implant label updated to include significantly lower risk of post-traumatic osteoarthritis following ...
The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...
The FDA proposes front-of-package "Nutrition Info boxes" to highlight saturated fat, sodium, and added sugars. The initiative aims to combat chronic diseases and promote healthier food choices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results